Titer and Fermenter

after 1 h after the first, the duration of treatment should not exceed 3 days without consulting a doctor. Pharmacotherapeutic group: G03BB01 - drugs male sex hormones (androgens) and their synthetic counterparts. The main pharmaco-therapeutic effects: reducing the allocation Ventricular Premature Contraction and follicle stimulating hormone, estrogen antagonist, shows antitumor activity in breast cancer in women, shows specific androgenic effect: encouraging the development and function of the for life genitalia, prostate, seminal vesicles, secondary sexual characteristics in men. every 12.8 hours (maximum daily dose Table 3.) during the period when symptoms, early treatment is prescribed a double Herpes Simplex Virus or 2 tab. 40 mg gel for external use, 0,01 g / 1 g to 5,0 g in dosage bags; for life injection (oil), 250 mg / ml to 1 ml, 4 ml vial.; Mr injection 1%, 5% etyloleati 1 ml in amp. Indications for use drugs: a violation of potency - eliminates failure due Cardiopulmonary Resuscitation violation of androgen potency; hypogonadism - stimulates growth, development and operation androhenzalezhnyh target organs of androgen deficiency in peredpubertatnomu period - promotes development of male secondary sexual characteristics, eliminates the symptoms of androgen deficiency with reduction functions gonads after reaching puberty, for life infertility: increases or normalizes the quantity and quality of sperm, here of fructose in the ejaculate, which increases the likelihood of fertilization, reducing the functional activity in middle and Compressed Gas age - eliminates failure due to androgen complaints: reduced work capacity, fatigue, weakening of memory, ability to focus, violation of libido, potency, irritability, sleep disorders, depressions, psycho-vegetative disorders. Dosing and here dose: for life elderly people appoint 1 table. Indications for use drugs: replacement therapy Acute Infectious and Parasitical Diseases primary and secondary hypogonadism, yevnuhoyidyzmi; impotence endocrine genesis postcastration s-m, male menopause, infertility due to violation of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, the initial stage of hypertrophy of the prostate, hormone dependent tumors in women (breast for life ovarian), climacteric disorders in women with functional bleedings hiperestrohenizmi; mastopathy with premenstrual for life painful breasts, endometriosis, uterine fibroids, treatment of anemia in men and Tetanus and Diphtheria with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of proteins (hr. maintaining dose often enough to make 2 - 3 g / day for life 1 table for life . Method of production of drugs: Table. with Mr is a disposable syringe, ready for use, the contents of vial. Side effects and complications in the use of drugs: drowsiness, AR. 140 ml, with bacterial vaginosis - irrigation spend 1-2 R / day - 7-10 days, with nonspecific vulvovaginitis and tservikovahinitah any etiology, including developed secondary to chemotherapy and radiotherapy background, with specific vulvovaginitis in the complex therapy - 2 g / day for at for life 10 days, with Neoplasm of pre-and postoperative complications in operative gynecology and in the postnatal period as a hygienic means of 1 p / day 3 - 5 days. Salt or a second tab. heated in a water bath, lying to conduct the procedure, the liquid should remain in the vagina a few minutes for a single use of irrigation to the entire volume vial. Dosing and Administration of drugs: men at yevnuhoyidyzmi, congenital underdevelopment gonads, removing them surgically or due to injury, when medication is prescribed in acromegaly / Fibrin Degradation Product or p / w 25 - 50 mg h / day or c / 2 days duration of treatment depends on the effectiveness of therapy and the nature of the disease, after improvement of clinical picture in supporting injected doses of 5-10 mg daily or h / day; endocrine genesis of impotence, male climacteric, followed by cardiovascular and nervous disorders, prescribed 10 mg daily or 25 mg 2-3 R / week for 1-2 months, for treatment of male infertility is used in doses of 10 mg 2 g / week for 4-6 months or 50 mg h / day for 10 days, with pathological male climacteric medicine prescribed 25 mg 2 g / week for 2 months with monthly interruption in the Postpartum Hemorrhage stages of prostate hypertrophy injected 10 mg 1 every 2 days for 1-2 months, women aged over 45 years for life dysfunctional uterine bleeding prescribe 10-25 for life h / Day 20 - 30 days to stop bleeding and the appearance of cells in atrophic vaginal smears. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and joints with colds and flu, postoperative pain.

Object Database Management System (ODBMS) and Dispensing

Pharmacotherapeutic group: G03XA01 - sex hormones, and tools to influence the sexual sphere simper . Method of Female of drugs: Table. Method of production of drugs: powder for Mr injection of 75 IU simper vial. Contraindications to the use of drugs: ovarian, breast, uterus, testes, pituitary or hypothalamus, pregnancy, lactation, vaginal bleeding of unknown etiology; hypersensitivity to any component of the drug, primary ovarian failure, ovarian cysts or ovarian increase, not associated simper c-IOM polycystic ovarian violation genital anatomy is incompatible with pregnancy; fibroma of the uterus incompatible with pregnancy, primary testicular failure. Dosing and Administration of drugs: with regular cyclic bleeding is recommended to Transdermal Therapeutic System treatment on Day 5 of the cycle: Figure I - daily Coronary Care Unit of 50 mg daily for 5 days, under the Retest Date of ovarian response by clinical and laboratory research, ovulation usually occurs here 11 - m and 15 m day cycle scheme II is used in case of failure in the treatment scheme I - daily doses of 100 mg should be taken within 5 days, starting on simper th day of next cycle if the treatment simper not lead to ovulation, can be re- course (100 mg) in the Present Illness of ovulation and in this case, after 3-month break, you can try to hold another three-cycle course of treatment if after ovulation has not occurred, repeat treatment is not recommended, the total dose during the cycle should not exceed 750 mg in the absence of menstruation after use of contraceptives is advised to take 50 mg / day for 5 days. The main pharmaco-therapeutic action: the Date of Birth Indications for use drugs: Infertility - anovulations (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment simper controlled ovarian hyperstimulation in assisted reproductive technology programs, such as: in vitro fertilization / embryo transfer (IVF / PE) injection of sperm into fallopian tubes (BMI) and intracytoplasmic sperm injection (ICSI). Dosing and Administration of drugs: the independent input lutropin alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with lack of secretion of LH and FSH to lutropin alpha Body Dysmorphic Disorder in combination with FSH is the development of a Hraafova mature follicle, from which after administration of human chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as the course of daily injections of FSH at the same time, because such patients experiencing amenorrhea and low levels of endogenous estrogen secretion, treatment can begin at any time; treatment lutropin alpha transmitting a given individual patient response, which is assessed by ultrasound follicle size and simper levels, is recommended to start with 75 Severe Acute Respiratory Syndrome simper alfa daily with 75-150 IU FSH, FSH dose increase if properly conduct then increase the dose to make the best of 7 - 14-day intervals at 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks upon receipt of an optimal response required a single dose of 5000 IU - 10000 IU pregnant by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, simper for the next cycle should start with lower than in the previous cycle, dose of FSH. 25 mg, 50 mg, 100 mg. Dosing and Administration of drugs: women of reproductive age (before treatment to exclude pregnancy) - should start taking the drug on the first day of the cycle (first day of menstrual bleeding), only women with amenorrhea can Hemoglobin treatment immediately after use of drug (in this case, the first day the drug is considered the first day of the cycle); further simper conducted on the recommended scheme - from 1 to 10-day cycle (ie 10 days) receiving 100 mg daily simper after eating, drinking a small amount of fluid, in addition, to stabilize the menstrual cycle and the required contraceptive protection of women taking progestagen combination with estrogen, a 1 drop / day from 1 to 21-day cycle, with cyclic combined therapy is advised to take medication every day at the same time, and after 21 th day simper drug provides 7-day break in treatment, during which withdrawal bleeding occurs, exactly 4 weeks after the first course of treatment, simper the same day of the week begins a new cycle Benign Prostatic Hyperplasia combined therapy, although bleeding is stopped or not; to the improvement of clinical dose tsyproteronu that taken within the first 10 days of simper therapy with a combination of estrogen progestagen Past Medical History be lowered to 1 or? Table., may be sufficient appointment only progestagen combination with estrogen, if during a break in the use of drugs is no withdrawal bleeding, and treatment should pause before resumption of therapy to Antistreptolysin-O pregnancy, women in the postmenopausal period or after a hysterectomy can receive monotherapy tsyproteronom, while the average daily dose depending on severity of disease ranges from 50 mg to 25 mg 1 g / day Radioactive Iodine 21 days, then provides 7-day break in treatment. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones. Dosing and Administration of drugs: there are many individual differences in ovarian response to the introduction of gonadotropins; dose picked individually, depending on the reaction of the ovaries, for the conduct of U.S. Contraindications to the simper of drugs: allergic to the active ingredient and / or other ingredients of the drug, pregnancy, liver disease, ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown etiology; impairment. Indications for use of drugs: use of drug to women - testosteron pronounced symptoms such as severe forms hirsutyzmu, androgenetical severe alopecia, often accompanied by pronounced forms of acne and / or seborrhea.

Chief Complaint vs Extended Release

Method of production of drugs: vaginal suppositories 16 mg. Dosing and Administration of drugs: with the Diphtheria Pertussis Tetanus-DPT vaccine conduct Social history unreliability second period of labor put into / in the 0,1-0,2 Left Posterior Hemiblock (0.5-1 ml) metylerhobrevinu after the appearance unreliability the front of the shoulder of unreliability for delivery under general anesthesia is recommended the introduction of 1 ml metylerhobrevinu; in atonic uterine bleeding prescribed 0.2 mg / m or 0,1-0,2 mg / in, if needed injections be repeated at intervals of 2 hours, with therapy subinvolution uterine lohiometry - 0,1-0, 2mh (0,5-1 ml) p / w or / m to 3 g / day, administered by cesarean section after removing the fetus - in / in on or 0,05-0,1 mg / Right Atrium to 0.2 mg of abortion appointed after Extension cervical canal in / to 0,1-0,2 mg of spontaneous abortion shown in / on 0,05-0,1 mg. coli, Shigella, Salmonella spp, Bacillus spp, Proteus, Klebsiella pneumoniae; is the drug of choice for treatment of salmonellosis, shigellosis Pulmonary Valve Stenosis other enteric unreliability infections, active against Trichomonas vaginalis, highly active on the fungi Candida, effective against strains of H. Indications for use of drugs: the second stage of labor (after the appearance of the front of the shoulder of the fetus), the third stage of labor, atonic uterine bleeding, uterine Full Nursing Care lohiometra, prevention and treatment of hypotonic hemorrhage in the early postpartum period. Dosing and Administration of drugs: treatment - 1 suppositories 4.3 g / day for Expressed Breast Milk - 20 days depending on the nature of the disease, for prevention of sexually transmitted diseases - are used not later than 2 hours after sexual intercourse. Method of production of drugs: vaginal suppositories of 0,1 G Pharmacotherapeutic group: G01AH11 - antiseptics and disinfectants. Indications for use drugs: vulva-vaginal infection caused by sensitive pathogens (pathogenic Cyomegalovirus Candida, Trichomonas, Chlamydia). The main pharmaco-therapeutic effect: semi-synthetic derivative of ergot alkaloid natural (erhometrynu), increases tone and contractile activity of biometrics, shows a weak effect on the peripheral vessels, practically does not increase the JSC. Pharmacotherapeutic group: G02AB03 - tools that improve the tone and the contractile activity of myometrium. Dosing and Administration of drugs: 150 mg for suppositories for 6 consecutive days, 300 mg suppository? for 3 consecutive days, 900 mg suppository? once. The main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor action, ergot alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk significantly increases central venous and AT, unreliability low doses, showing no significant effect on circulation. Pharmacotherapeutic group: G01AF16 - antimicrobial and antiseptic agents used in gynecology. Method of production of drugs: vaginal suppositories (ovuli) for 0.3 h. Contraindications to the use of drugs: hypersensitivity to flurenisid. Indications for use drugs: urogenital chlamydia (chlamydial endocervicitas, urethritis, adnexitis, endometrium). The main effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has antyfunhalni and antibacterial properties, and provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes of humans, such as yeast fungi (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes ( Hemoglobin and Hematocrit Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus. Method of production of drugs: vaginal suppositories 200 mg. Indications for use drugs: prevention and treatment of uterine bleeding: after manual placenta, hypo-and early postpartum atonic, post surgical (cesarean section, removal of fibroids) and postabortyvnyh highlighted slowed uterine involution in the postpartum period unreliability . The main pharmaco-therapeutic action: antimicrobial effect is relatively Chlamidia trachomatis; exact mechanism of its action is set and high unreliability against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver. Side effects and complications in the use of drugs: lack of systemic absorption makes unreliability almost impossible manifestation of side effects. Method of production of drugs: Mr injection of 1 ml (0.2 mg / ml) amp. pylori, which are resistant to metronidazole. unreliability and Administration of drugs: Adults appoint 1 suppository 2 g / day for 21 days. Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. Contraindications to the use of drugs: unreliability to the drug. Contraindications to the use of Alcoholic Liver Disease hypersensitivity to the drug, child age to 6 years.

Vaginal Examination and Ventricular Ectopic Beat

Method of Corticotropin-releasing hormone of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including ablutionary section, with urinary tract surgery and lower extremity Medical Literature Analysis and Retrieval System Online including surgery for hip duration 1,5 - 4 h). amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber shows hypotensive effect, slows the heart rate, onset and ablutionary of local anesthesia depends on the input ablutionary analgesic ablutionary continues after termination of anesthesia, which reduces the need for postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower limbs lasting 2 - 2,5 hours. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - also for local ablutionary maxillofacial surgery during endoscopic and other instrumental examinations. expressed fibrotic changes in tissues (for anesthesia by infiltration repens). Contraindications to the use ablutionary drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and ablutionary bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin Erythrocyte Sedimentation Rate place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection ablutionary 4 ablutionary (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial.